osypkamed.com
News | Osypka Medical | Cardiotronic
http://www.osypkamed.com/news
We are proud to announce the release of firmware 1.30 for the PACE 203. The new software provides the user unprecedented control over cardiac stimulation by leveraging the most fundamental electrical property- Ohm’s Law. The PACE 203 is the only external pacemaker to instantaneously show the voltage and current applied to the patient along with the impedance of the lead system. More information can be found here. In order to help find new, improved treatments for newborns. Hemodynamic profile of patients...
pangeastudy.com
Pangea
http://www.pangeastudy.com//index.aspx
PANGEA is an international prospective point prevalence study with follow-up outcomes to investigate the epidemiology of acute critical neurologic disease in children. April 30th, 2013. Poster presentation of the first abstract from PANGEA at the International Symposium on Intensive Care and Emergency Medicine meeting in Brussels, Belgium, March 2013. Click here to download/see the poster ( pptx format. The Laerdal Foundation for Acute Medicine. Department of critical care medicine UPMC.
pangeastudy.com
Pangea study website
http://www.pangeastudy.com/media/html/about_us.html
About the Safar Center. The Safar Center for Resuscitation Research. At the University of Pittsburgh School of Medicine. And Children's Hospital of Pittsburgh. In addition to conducting basic research, the Safar Center also provides training to the next generation of resuscitation researchers. The Center is a 20,000 square-feet freestanding research facility that houses the laboratories of scientists and clinician-scientists working across a broad spectrum of fields important to resuscitation medicine.
pangeastudy.com
Pangea study website
http://www.pangeastudy.com/media/html/about_study.html
About the PANGEA study. Acute critical neurologic injury in children due to traumatic brain injury, cardiac arrest, stroke, seizures, central nervous system infection, and spinal cord injury is associated with significant morbidity and mortality and enormous economic burden worldwide. Treatment for acute brain injury in children is largely supportive and new therapies are critically needed. The long term objectives of this study are four-fold:. 2) To assist in the design of prospective clinical research,.
pangeastudy.com
Pangea study website
http://www.pangeastudy.com/media/html/faq.html
1 We expect regulatory approval soon (within a few weeks) - can we still participate in the first study date? Yes, it is possible. If this is the case, please let us know right away and please email us the approval letter when you receive it. Procedural details will follow. Remember, you cannot collect data or input it into the website until you have local regulatory approval. 2 Do ventriculoperitoneal shunt (and other central nervous system [CNS] shunts) infections meet the criteria of CNS infection?
pangeastudy.com
Pangea study website
http://www.pangeastudy.com/media/html/centers.html
Pangea study participating centers. Click here for a complete list of investigators and study coordinators. United States and Canada. Ann and Robert H. Lurie Children's Hospital of Chicago. Children’s Medical Center at Dallas. Children's Healthcare of Atlanta. Children's Hospital and Medical Center (Omaha, NE). Children's Hospital and Research Center Oakland. Children's Hospital Los Angeles. Children's Hospital of Boston. Children's Hospital of Philadelphia. Children's Hospital of Pittsburgh. Children's ...
plasmatransfusion.org
Plasma Transfusion
http://www.plasmatransfusion.org/current_study.htm
Based on observational data, plasma transfusions might increase the risk of morbidity if not given to the right patients. Therefore, we are planning a large randomized controlled trial to assess plasma transfusion strategies. Before we get there, we need some more information. We have designed a point-prevalence study on plasma transfusions, which has been endorsed by the Canadian Critical Care Trials Group ( CCCTG. The Pediatric Acute Lung Injury and Sepsis ( PALISI. The study begins on April 7th, 2014.
cardiotronic.net
News | Osypka Medical | Cardiotronic
http://www.cardiotronic.net/news
We are proud to announce the release of firmware 1.30 for the PACE 203. The new software provides the user unprecedented control over cardiac stimulation by leveraging the most fundamental electrical property- Ohm’s Law. The PACE 203 is the only external pacemaker to instantaneously show the voltage and current applied to the patient along with the impedance of the lead system. More information can be found here. In order to help find new, improved treatments for newborns. Hemodynamic profile of patients...
